ADH-1, Gemcitabine Hydrochloride & Cisplatin in Treating Metastatic Pancreatic or Biliary Tract Cancer

NCT01825603 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Ampulla of Vater Adenocarcinoma
Gallbladder Adenocarcinoma
Metastatic Pancreatic Adenocarcinoma
Pancreatic Adenocarcinoma
Stage III Ampulla of Vater Cancer
Stage III Intrahepatic Cholangiocarcinoma
Stage III Pancreatic Cancer
Stage IIIA Gallbladder Cancer
Stage IIIA Hilar Cholangiocarcinoma
Stage IIIB Gallbladder Cancer
Stage IIIB Hilar Cholangiocarcinoma
Stage IV Ampulla of Vater Cancer
Stage IVA Gallbladder Cancer
Stage IVA Hilar Cholangiocarcinoma
Stage IVA Intrahepatic Cholangiocarcinoma
Stage IVA Pancreatic Cancer
Stage IVB Gallbladder Cancer
Stage IVB Hilar Cholangiocarcinoma
Stage IVB Intrahepatic Cholangiocarcinoma
Stage IVB Pancreatic Cancer

Interventions

DRUG: ADH-1
DRUG: Cisplatin
DRUG: Gemcitabine Hydrochloride
OTHER: Laboratory Biomarker Analysis

Sponsor

University of Nebraska

Collaborators

[object Object]
[object Object]